ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 12 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 3E0K7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K7SF | Introduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K7TZ | Introduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening | Valid |
| 3E0K804 | Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K805 | Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K80M | Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K828 | Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K829 | Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K83Z | Introduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K86Z | Introduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K87Z | Introduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K8BZ | Introduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K8GC | Introduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K8HZ | Introduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K8KZ | Introduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K8SF | Introduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0K8TZ | Introduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0L05Z | Introduction of Adhesion Barrier into Pleural Cavity, Open Approach | Valid |
| 3E0L304 | Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L305 | Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L30M | Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L317 | Introduction of Other Thrombolytic into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L328 | Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L329 | Introduction of Other Anti-infective into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L33Z | Introduction of Anti-inflammatory into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L35Z | Introduction of Adhesion Barrier into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L36Z | Introduction of Nutritional Substance into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L37Z | Introduction of Electrolytic and Water Balance Substance into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L3BZ | Introduction of Anesthetic Agent into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L3GC | Introduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L3HZ | Introduction of Radioactive Substance into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L3KZ | Introduction of Other Diagnostic Substance into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L3SF | Introduction of Other Gas into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L3TZ | Introduction of Destructive Agent into Pleural Cavity, Percutaneous Approach | Valid |
| 3E0L45Z | Introduction of Adhesion Barrier into Pleural Cavity, Percutaneous Endoscopic Approach | Valid |
| 3E0L4GC | Introduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Endoscopic Approach | Valid |
| 3E0L704 | Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Via Natural or Artificial Opening | Valid |
| 3E0L705 | Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening | Valid |
| 3E0L70M | Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening | Valid |
| 3E0L7SF | Introduction of Other Gas into Pleural Cavity, Via Natural or Artificial Opening | Valid |
| 3E0M05Z | Introduction of Adhesion Barrier into Peritoneal Cavity, Open Approach | Valid |
| 3E0M304 | Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M305 | Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M30M | Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M30Y | Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M328 | Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M329 | Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M33Z | Introduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M35Z | Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M36Z | Introduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M37Z | Introduction of Electrolytic and Water Balance Substance into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M3BZ | Introduction of Anesthetic Agent into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M3GC | Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M3HZ | Introduction of Radioactive Substance into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M3KZ | Introduction of Other Diagnostic Substance into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M3SF | Introduction of Other Gas into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M3TZ | Introduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach | Valid |
| 3E0M45Z | Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Endoscopic Approach | Valid |
| 3E0M4GC | Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Endoscopic Approach | Valid |
| 3E0M704 | Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Via Natural or Artificial Opening | Valid |
| 3E0M705 | Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening | Valid |
| 3E0M70M | Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening | Valid |
| 3E0M7SF | Introduction of Other Gas into Peritoneal Cavity, Via Natural or Artificial Opening | Valid |
| 3E0N304 | Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N305 | Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N30M | Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N328 | Introduction of Oxazolidinones into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N329 | Introduction of Other Anti-infective into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N33Z | Introduction of Anti-inflammatory into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N36Z | Introduction of Nutritional Substance into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N37Z | Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N3BZ | Introduction of Anesthetic Agent into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N3GC | Introduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N3HZ | Introduction of Radioactive Substance into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N3KZ | Introduction of Other Diagnostic Substance into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N3SF | Introduction of Other Gas into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N3TZ | Introduction of Destructive Agent into Male Reproductive, Percutaneous Approach | Valid |
| 3E0N4GC | Introduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Endoscopic Approach | Valid |
| 3E0N704 | Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N705 | Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N70M | Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N728 | Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N729 | Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N73Z | Introduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N76Z | Introduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N77Z | Introduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N7BZ | Introduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N7GC | Introduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N7HZ | Introduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N7KZ | Introduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N7SF | Introduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N7TZ | Introduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening | Valid |
| 3E0N804 | Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N805 | Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |
| 3E0N80M | Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic | Valid |